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1. Introduction 
Hypoglycemia is a biochemical symptom, which refers to the presence of an underlying 
cause. As glucose is the fundamental energy currency of the cell, disorders that affect its 
availability or its use can cause hypoglycemia (DePuy et al., 2009, Schaefer-Graf et al., 2002). 
Glucose is a source of energy storage in the form of glycogen, fat, and protein and 
hypoglycemia is the most common metabolic problem among pediatric patients in the 
critical care medicine (DePuy et al., 2009, Tita et al., 2009, Adamson et al., 1995, Alkalay et 
al., 2006). The lower limit of the accepted normal value of blood glucose level in newborn 
infants with associated illness especially in presence of hypoxemia and ischemia that 
already impairs the cerebral metabolism has not been determined (Sperling et al., 2008, 
Alkalay et al., 2006). Moreover, there are controversies regarding the definition of 
hypoglycemia (Cornblath et al., 2000). However, some reasonably accepted definitions of 
hypoglycemia for the purpose of the clinical management of the entity are in practice. In 
children, a blood glucose value of less than 40 mg/dL (2.2 mmol/L) represents 
hypoglycemia (Tita et al., 2009, Guideline, 2004, Jain et al., 2008). A plasma glucose level of 
less than 30 mg/dL (1.65 mmol/L) in the first 24 hours of life and less than 45 mg/dL (2.5 
mmol/L) thereafter constitutes hypoglycemia in the newborn (DePuy et al., 2009, Tita et al., 
2009, Daly et al., 2003, Guideline, 2004, Cornblath et al., 2000). However, in children with 
severe acute malnutrition (SAM) the cutoff value is a bit high, and, a blood glucose value of 
less than 54 mg/dL (3.0 mmol/L) represents hypoglycemia (WHO, 1999, Ahmed et al., 
1999). 
2. Incidence of hypoglycemia 
Incidence of hypoglycemia varies with the definition, population, method and timing of 
feeding, and the type of glucose assay (Guideline, 2004). The age is also helpful in assessing 
the probable diagnosis of hypoglycemia. The incidence is highest in the immediate post 
neonatal period (Halamek et al., 1997a, Cornblath and Ichord, 2000). The incidence 
decreases with increasing age (Halamek et al., 1997a, DePuy et al., 2009).  
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The overall incidence of symptomatic hypoglycemia in newborns varies from 1.3-3 per 1000 
live births (Cranmer, 2009, Guideline, 2004). Serum glucose levels are higher than whole 
blood values (Cowett and Loughead, 2002, Deshpande and Ward Platt, 2005). The incidence 
of hypoglycemia is greater in high-risk neonatal groups (DePuy et al., 2009, Guideline, 2004, 
Cornblath and Ichord, 2000). Hypoglycemia is more common in premature neonates 
especially born at less than 37 weeks of gestation and in those especially born at more than 
40 weeks gestation, with incidence rates of 2.4% in neonates born at 37 weeks' gestation, 0.7-
1.8% in neonates born at 38-42 weeks of gestation (Tita et al., 2009, Narchi and Skinner, 2009, 
Cornblath and Ichord, 2000). The incidence of hypoglycemia in children older than 6 months 
in a large urban critical care department was 0.034% (Daly et al., 2003). In a recent Japanese 
study, more than 80% of admissions from the nursery to the neonatal ICU after birth were 
due to apnea or hypoglycemia in neonates born at 35-36 weeks' gestation (Ishiguro et al., 
2009).  Incidence of hypoglycemia among 1-5 years old children with acute gastroenteritis 
and dehydration was found 9.2% (Reid and Losek, 2005). However, study conducted among 
the hospitalized malnourished children in the critical care medical units of the developing 
countries, 16-39% were found to be hypoglycemic on admission (Bennish et al., 1990, Huq et 
al., 2007, Chisti et al., 2010). 
Early feeding decreases the incidence of hypoglycemia (Wight, 2006, Meier et al., 2007, 
Chertok et al., 2009). The incidence of inborn errors of metabolism that lead to neonatal 
hypoglycemia are rare but can be screened in infancy (Schwartz, 1997b, Guideline, 2004, 
Cranmer, 2009):  
Common inborn errors of metabolism:  
 Carbohydrate metabolism disorders (>1:10,000)  
 Fatty acid oxidation disorders (1:10,000)  
 Hereditary fructose intolerance (1:20,000 to 1:50,000)  
 Glycogen storage diseases (1:25,000)  
 Galactosemia (1:40,000)  
 Organic acidemias (1:50,000)  
Uncommon inborn errors of metabolism: 
 Phosphoenolpyruvate carboxykinase deficiency  
 Primary lactic acidosis  
3. Objectives 
- To develop a guideline for the physicians and nurses working at the critical care 
medicine in the developing countries for the bed side diagnosis and prompt 
management of hypoglycemia and  
- To evaluate its role as a predictor of fatal outcome in children with SAM.  
4. Options 
- Clinical assessment 
- Bed side testing 
- Prompt bed side management 
- Empirical antimicrobial therapy according to cause 
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5. Benefits of this chapter  
- Increase awareness for the rapid diagnosis of hypoglycemia in children with SAM, and 
those with dehydrating diarrhea 
- Better utilization of the available diagnostic equipments 
- Understanding the value of rapid management of hypoglycemia in children with SAM 
- Understanding the need for antimicrobial therapy according to cause 
- Decreased morbidity and mortality due to hypoglycemia 
- Increase the awareness of the causes of pediatric hypoglycemia 
- Immediate diagnosis 
- Prompt treatment 
- Reduced cost associated with unnecessary investigations and complications due to 
inappropriate treatment 
6. Importance of the chapter  
Health professionals in developing countries often rely on clinical signs to predict the 
severity of disease in hospitals with limited facilities, which is often reliable in children with 
better nutritional status (WHO, 2005, Chisti et al., 2009c) but severely malnourished children 
often have severe infection (Chisti et al., 2010) and die without any prior overt clinical signs, 
which may prevent their appropriate and timely management (Suskind and Suskind, 1990, 
Morgan, 1997). Laboratory investigation, an essential alternative measure of suppressed 
clinical signs, often involves many efforts, time and cost, as in blood culture. Availability of 
pertinent laboratory investigations in resource poor settings is very limited. Furthermore, 
data on simple, less time-consuming and inexpensive laboratory diagnostic tool(s) that can 
predict the outcome of such infants are scarce. However, limited data for predicting factors 
of fatal outcome in severely malnourished children in pediatric critical care medicine 
revealed that hypoglycemia, measured by a simple portable bedside glucose test, is 
significantly associated with fatal outcome especially in children presenting with SAM 
(Chisti et al., 2010, Huq et al., 2007). It may be a useful rapid diagnostic test, allowing 
prompt comprehensive management of such children following WHO guidelines (WHO, 
2005), thus reducing deaths even in resource poor settings.  
7. Associated factors of hypoglycemia  
Hypoglycemia is common in critically ill children and is associated with increased mortality 
rates in critically ill nondiabetic children (Faustino and Bogue, Cornblath and Ichord, 2000, 
Reid and Losek, 2005). A recent study by Faustino et al. showed that hypoglycemia was 
associated with worsening organ function (Faustino and Bogue) and concluded that  it may 
be a marker of severity of illness. He also suggested that further investigations are needed to 
establish the mortality risk with hypoglycemia due to the effect of insulin compared to 
spontaneous hypoglycemia (Faustino and Bogue). One recent study revealed that infants 
with serious illness such as sclerema requiring admission to critical care medicine in an 
urban diarrhea hospital were significantly associated with hypoglycemia (Chisti et al., 
2009a). Another study from the same center revealed that patients with enteric 
encephalopathy having fatal outcome more often presented with hypoglycemia compared 
to those who survived (Chisti et al., 2009b). 
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A most recent study from the critical care ward of Dhaka hospital of ICDDR,B revealed that 
among all relatively rapid laboratory investigations in neonates, hypoglycemia  was the 
independent predictor of fatal outcome (Table 1). The study revealed that to predict death, 
the sensitivity, specificity, and positive predictive value of hypoglycemia with their 95% 
confidence intervals were 40% (14–73%), 88% (75– 95%), and 40% (14–73%), respectively 
(Chisti et al., 2010). The study concluded that most of the laboratory markers used to predict 
fatal outcome in diarrheal infants with SAM  take several hours to become available, except 
a bedside glucose test, which takes less than a minute  but is inexpensive. The study 
suggested that presence of hypoglycemia, measured by a portable bedside glucose test, is 
significantly associated with fatal outcome with high specificity in infants presenting with 
diarrhea and SAM (Chisti et al., 2010). It may be a useful rapid diagnostic test allowing 
prompt detection  followed by comprehensive management of such infants according to 
WHO guidelines, which would help in reducing deaths even in resource poor settings 
(WHO, 2005).  The findings of the study was also supported by another previous study from 





N = 10 (%)
Survivor 
N = 51 (%)
Non-adjusted  Adjusted 
OR (95% CI) p value OR (95% CI) p value 
Hypoglycemia  4 (40) 6 (12) 5.0 (1.01 - 29.8) 0.027 5.0 (1.1 - 23.0) 0.039 
Abnormal WBC 
count 
6 (60) 36 (71) 0.6 (0.1 - 3.1) 0.710 0.5 (0.1 – 2.5) 0.438 
Higher S. CRP 
level 
9 (90) 33 (65) 4.9 (0.6 - 111.7) 0.151 4.5 (0.5 - 39.5) 0.179 
Hyponatremia 3 (30) 14 (28) 1.1 (0.2 - 6.0+) 1.00 0.8 (0.2 - 4.2) 0.813 
Hypokalemia 4 (40) 25 (49) 0.7 (0.1 - 3.3) 0.735 2.2 (0.3 - 14.4) 0.409 
Hypocalcemia 4 (40) 11 (22) 2.4 (0.5 - 12.4) 0.243 1.8 (0.3 - 10.2) 0.529 
Hypomagnesemia  0 (00) 2 (4) 0.0 (0.0 - 23.5) 1.00 0.0 (0.0 - unidentified) 1.0 
OR: odds ratio, CI: confidence interval, S: serum, CRP: C-reactive protein. 
Illustrated from the Tropical Medicine and International Health by Chisti et. al. (2010) 
Table 1. Comparison of the characteristics of severely malnourished infants with fatal 
outcome and those who survived 
8. Hypoglycemia and glucose metabolism  
Malnutrition is a major risk factor for death in children in developing countries (Faruque et 
al., 2008), and the mortality risk is higher in infants when they present with severe form of 
malnutrition (Pelletier et al., 1994, Naheed et al., 2009, Chisti et al., 2009c), especially in a set 
up with critical care medicine (Elusiyan et al., 2006). It has not received enough attention in 
developing countries. The primary therapy is very simple by immediate infusion of 
intravenous glucose. The occurrence of hypoglycemia is directly related to energy balance 
and determined by the availability of glucose, free fatty acids and ketone bodies in the tissue 
(Nuoffer and Mullis, 2005, Fluck et al., 2003, Mohnike and Aynsley-Green, 1993). An intact 
energy balance and maintenance of normal blood sugar concentration is dependent upon: 
an adequate caloric and qualitative dietary intake; a functionally intact hepatic 
glucogenolytic and gluconeogenic enzyme system; an adequate supply of endogenous 
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gluconeogenic substrates (lactate, amino acids and glycerol); an adequate energy supply 
provided by the beta-oxidation of fatty acids to synthesize glucose and ketone bodies and a 
normal endocrine system (insulin, glucagon, catecholamines and growth hormone) for 
integrating and modulating these processes (Nuoffer and Mullis, 2005, Mohnike et al., 1993). 
Disturbances in each of these factors may lead to hypoglycemia. Glucose has an essential 
and fundamental importance for the brain metabolism. The major contribution of the brain 
to the basal metabolic rate is an important factor contributing to the frequency and severity 
of a hypoglycemic syndrome in the pediatric age (Nuoffer and Mullis, 2005, Mohnike et al., 
1993). Cerebral glucose uptake occurs through a glucose transporter molecule and these 
molecules are carrier mediated and facilitate diffusion process that is dependent on blood 
glucose concentration but cerebral and cerebrospinal fluid (CSF) glucose uptake are not 
regulated by insulin (Sperling et al., 2008). Paucity of glucose transporter molecule can 
result in seizures due to reduced cerebral and CSF glucose concentrations although there 
might have normal blood glucose levels (Sperling et al., 2008, Mohnike et al., 1993). Thus, 
hypoglycemia should be considered as a medical emergency and treated very aggressively 
especially in children with other associated illnesses such as SAM, severe sepsis, septic 
shock, febrile neonates, prematurity and low birth weight in the critical care medicine ward.  
9. Pathophysiology of hypoglycemia  
Normal blood glucose is very narrowly regulated, usually from 4.4-5 mmol/L. Glucose 
levels increase transiently after meals to 6.6-7.7 mmol/L. Feedback systems return the 
glucose concentration rapidly back to the preprandial level, usually within 2 hours after the 
last absorption of carbohydrates (Fleisher, 2000, Halamek and Stevenson, 1998, Reid et al., 
2003, Sperling et al., 2008). 
Insulin and glucagon are the important hormones in the immediate feedback control system 
of glucose (Sperling et al., 2008). When blood glucose increases after a meal, the rate of 
insulin secretion increases and stimulates the liver to store glucose as glycogen (Halamek et 
al., 1997b). When cells (primarily liver and muscle) are saturated with glycogen, additional 
glucose is stored as fat (Reid et al., 2003).  
When blood glucose levels fall, glucagon secretion functions to increase blood glucose levels 
by stimulating the liver to undergo glycogenolysis and release glucose back into the blood 
(Sperling et al., 2008, Halamek et al., 1997b).  
In starvation, the liver maintains the glucose level via gluconeogenesis (Sperling et al., 2008). 
Gluconeogenesis is the formation of glucose from amino acids and the glycerol portion of fat. 
Muscle provides a store of glycogen and muscle protein breaks down to amino acids, which 
are substrates utilized in gluconeogenesis in the liver (Narayan et al., 2001). Circulating fatty 
acids are catabolized to ketones, acetoacetate, and B-hydroxybutyrate and can be used as 
auxiliary fuel by most tissues, including the brain (Fleisher, 2000, Sperling et al., 2008).  
The hypothalamus stimulates the sympathetic nervous system, and epinephrine is secreted 
by the adrenals causing the further release of glucose from the liver (Haninger and Farley, 
2001). Over a period of hours to days of prolonged hypoglycemia, growth hormone and 
cortisol are secreted and decrease the rate of glucose utilization by most cells of the body 
(Halamek and Stevenson, 1998).  
In the newborn, serum glucose levels decline after birth until 1-3 hours due to an abrupt 
transition from the intrauterine life, then they spontaneously increase, ultimately 
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characterized by the autonomous ability to maintain euglycemia. Liver glycogen stores 
become rapidly depleted within hours of birth, and gluconeogenesis, primarily from 
alanine, can account for 10% of glucose turnover in the newborn infant by several hours of 
age (Halamek and Stevenson, 1998).  
Neonatal hypoglycemia (Halamek and Stevenson, 1998, Sperling et al., 2008) 
 Inappropriate changes in hormone secretion 
 Inadequate substrate reserve in the form of hepatic glycogen 
 Inadequate muscle stores as a source of amino acids for gluconeogenesis 
 Inadequate lipid stores for the release of fatty acids 
Hypoglycemia in older infants and children (Sperling et al., 2008, Reid et al., 2003) 
 The pathophysiology of hypoglycemia is analogous to that in adults. 
 Glucose homeostasis is maintained by glycogenolysis in the immediate post feeding 
periods and by gluconeogenesis several hours after meals. 
Hypoglycemia in severely malnourished children:  
The pathophysiology of the hypoglycemia is poorly understood although there is popular 
belief that it is mainly due to severe infection in severely malnourished children. There is 
decreased endogenous glucose production (EGP) in severely malnourished children which 
is related to the degree of hypoalbuminemia and oxidative stress (Bandsma et al.). Severe 
malnutrition is associated with impaired glucose absorption and decreased glucose 
absorption correlates with oxidative stress in sick children who needs admission to the 
pediatric critical care medicine (Bandsma et al.). This potentially explains the etiology of 
hypoglycemia in severely malnourished children. Severe malnutrition in infants often 
causes depressed cell-mediated and humoral immune responses, associated with 
impairment of IgA production, chemotaxis, reduced mature T cells, and compromised 
phagocytic activity (Suskind and Suskind, 1990, Morgan, 1997). As a result, patients become 
highly susceptible to infectious disease, predominantly diarrhea, which is often associated 
with prolonged anorexia and vomiting (Feign. R and Garg, 1987). Failure of gluconeogenesis 
in such infants is a common phenomenon (Butler et al., 1989, Bennish et al., 1990) and 
potentially responsible for the development of fatal hypoglycemia. 
10. Causes/etiology of hypoglycemia  
Hypoglycemia events are usually accompanied by an increased heart rate with bounding 
pulse due to increased epinephrine secretion (Dubois et al., 1995). This leads the infant to be 
irritable, tremulous, and cranky (al-Rabeeah et al., 1995). In any case the brain energy supply 
is severely impaired; the mental status of the children is likely to be impaired with extreme 
inappropriate effect and mood, lethargy, seizure, or coma. Large body size for age in the 
neonate or older child suggests hyperinsulinism, although some children with 
hyperinsulinism are born prematurely and are small for gestational age (de Lonlay-Debeney 
et al., 1999, Stanley, 1997). Decreased subcutaneous fat as in severe malnutrition such as in 
severe wasting suggests inadequate glucose stores (de Lonlay-Debeney et al., 1999, Dubois 
et al., 1995). Poor linear growth may point to growth hormone deficiency, and midline facial 
and cranial abnormalities suggest pituitary hormone deficiencies (Dunne et al., 1997). Liver 
size should be assessed for evidence of glycogen-storage diseases. Etiology of hypoglycemia 
includes the following:  
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Potential causes of hyperinsulinism in children include maternal diabetes in pregnancy, 
persistent hyperinsulinemic hypoglycemia of infancy, insulin-producing tumors, and 
child abuse (Stanley, 1997). Hyperinsulinism causes excess glucose use primarily by 
stimulating skeletal muscle to uptake glucose. This is aggravated by insulin-induced 
suppression of hepatic glycogenolysis and gluconeogenesis (al-Rabeeah et al., 1995, 
Stanley, 1997).  
In neonates 
Hyperinsulinism is the most common cause of hypoglycemia in neonates. However, in 
addition to hyperinsulinism, or persistent hyperinsulinemic hypoglycemia of infancy 
(PHHI), hypoglycemia occurs due to limited glycogen stores (eg, prematurity, intrauterine 
growth retardation), depleted glycogen stores (eg, stress in perinatal asphyxia, starvation), 
in ketotic hypoglycemia, easily depleted glycogen stores, in combination with inadequate 
production of glucose through gluconeogenesis, contribute to hypoglycemia (Cranmer, 
2009, Guideline, 2004). Thus, fatty acid oxygenation is required to provide substrate for 
gluconeogenesis and ketogenesis. Ketones, the byproduct of fatty acid metabolism, are 
found in urine and represent the starved state. Increased glucose use (eg, hyperthermia, 
polycythemia, sepsis, growth hormone deficiency), decreased glycogenolysis, 
gluconeogenesis, or use of alternate fuels (eg, inborn errors of metabolism, adrenal 
insufficiency) (Cranmer, 2009, Guideline, 2004). 
In infants 
Hyperinsulinemia may be due to various genetic defects that cause a loss of glucose 
regulation of insulin secretion (Cosgrove et al., 2004, Tornovsky et al., 2004). This disorder 
is known as endogenous-persistent hyperinsulinemic hypoglycemia of infancy 
(previously termed nesidioblastosis) (Cosgrove et al., 2004, Stanley, 1997). No genetic 
defect is identified in 50% of patients with hyperinsulinism although unusual single 
nucleotide polymorphisms defects have been found that may be responsible in some 
infants (Di Candia et al., 2009).  
Infants of mothers with diabetes also have high insulin levels after birth due to the high 
glucose exposure in utero; the poorer the glucose control during pregnancy, the greater the 
likelihood of hyperinsulinism in the infant (Stanley, 1997). In older children, 
hyperinsulinemia is rare, but an insulin-producing tumor is the most common cause 
(Stanley, 1997). Exogenous administration of insulin or oral hypoglycemic agents, either 
accidental or due to abuse, must be considered (Di Candia et al., 2009).  
Overall criteria for the diagnosis of hyperinsulinism in the infant (Sperling et al., 2008) 
 Hyperinsulinemia (plasma insulin > 2 µU/mL) 
 Hypofattyacidemia (plasma free fatty acids < 1.5 mmol/L 
 Hypoketonemia (plasma β-hydroxybuterate < 2.0 mmol/L) 
 Inappropriate glycemic response to glucagon, 1 mg IV (delta glucose > 40 mg/dl)) 
10.2 Disorders of glucose underproduction 
This includes inadequate glucose stores which are associated with prematurity, infants who 
are small for gestational age, SAM, and ketotic hypoglycemia (Di Candia et al., 2009). 
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Among them, children with SAM who need admission to the critical care medicine have 
paramount importance. We will focus our discussion at the later part of the chapter. 
After insulin treatment in diabetes, the above mentioned disorders are the most common 
causes of hypoglycemia. These disorders are largely diagnoses of exclusion made after other 
causes of hypoglycemia are ruled out. Prematurity, infants who are small for gestational 
age, and SAM should be readily apparent based on the clinical situation. Ketotic 
hypoglycemia, which usually affects children with SAM and aged 18 months to 6 years, is 
usually due to disrupted food intake (Di Candia et al., 2009).  
Glycogen-storage disease type 0 (due to glycogen synthase deficiency) is associated with 
fasting hypoglycemia because of the liver’s inability to store glucose in the immediate 
postprandial state. Thus, the glucose load from the meal is anaerobically used rather than 
stored for later use. In this disorder, plasma glucose and lactate levels are high in the 
immediate postprandial state (Di Candia et al., 2009).  
Glycogen-storage disease type I (Due to disorders of hepatic glucose production include 
glucose-6-phosphatase deficiency), glycogen-storage disease type III (due to debrancher 
deficiency), and glycogen-storage disease type VI (due to hepatic phosphorylase deficiency), 
galactosemia, hereditary fructose intolerance, and maple syrup urine disease interfere in 
glucose production through various defects, including blockage of glucose release or 
synthesis or blockage or inhibition of gluconeogenesis. Children with these diseases may 
adapt to their hypoglycemia because of its chronicity (Di Candia et al., 2009).  
Hormonal abnormalities include panhypopituitarism, growth hormone deficiency, and 
cortisol deficiency (primary or secondary). As described above, growth hormone and 
cortisol play important roles in generating alternative fuels and stimulating glucose 
production. Because they are easily treatable abnormalities, early recognition is important 
(Di Candia et al., 2009).  
Toxins and other illnesses (ethanol, salicylates, propranolol, malaria) also cause 
hypoglycemia. Ethanol inhibits gluconeogenesis in the liver and can thus cause 
hypoglycemia. This is particularly true in patients with insulin-treated diabetes who are 
unable to reduce insulin secretion in response to developing hypoglycemia. Salicylate 
intoxication causes both hyperglycemia and hypoglycemia. The latter is due to 
augmentation of insulin secretion and inhibition of gluconeogenesis (Di Candia et al., 2009).  
11. Clinical features of hypoglycemia  
Glucose usually provides the primary source for brain energy. Clinical manifestations are 
broad and can be from a combination of adrenergic stimulation or from decreased 
availability of glucose for the CNS. Unlike older children, infants are not able to verbalize 
their symptoms and are particularly vulnerable to hypoglycemia (Cranmer, 2009). 
Symptoms of hypoglycemia occur through two main clinical pathways. The first one is 
caused by activation of the autonomic nervous system, which causes symptoms such as 
anxiety, tremulousness, diaphoresis, tachycardia, pallor, hunger, nausea, and vomiting 
(Dunne et al., 2004). The symptoms of second one is due to neuroglycopenia 
(hypoglycorrhachia) and consists of headache, mental confusion, staring, behavioral 
changes, difficulty concentrating, visual disturbances (eg, decreased acuity, diplopia), 
dysarthria, seizures, ataxia, somnolence, coma, stroke (hemiplegia, aphasia), paresthesias, 
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dizziness, amnesia, decerebrate or decorticate posturing (Dunne et al., 2004). There are other 
nonspecific symptoms which include dry mouth, mouth tingling, headache, nausea, and 
blurred vision (Dunne et al., 2004). 
During the first or second day of life, symptoms vary from asymptomatic to CNS and 
cardiopulmonary disturbances (Guideline, 2004). 
Following high risk groups does need screening for hypoglycemia in the first hour of life (Guideline, 
2004, Feign. R and Garg, 1987, Fleisher, 2000)  
 Newborns who weigh more than 4 kg or less than 2 kg 
 Large for gestational age infants who are above the 90th percentile, small for gestational 
age infants below the 10th percentile, and infants with intrauterine growth  
restriction 
 Infants born to insulin-dependent mothers or mothers with gestational diabetes  
 Gestational age less than 37 weeks 
 Newborns suspected of sepsis or born to a mother suspected of having 
chorioamnionitis 
 Newborns with symptoms suggestive of hypoglycemia, including jitteriness, 
tachypnea, hypotonia, poor feeding, apnea, temperature instability, seizures, lethargy  
In addition, consider hypoglycemia screening in infants with following conditions: 
(Guideline, 2004).  
 Significant hypoxemia 
 Perinatal distress  
 5-minute APGAR scores less than 5  
 Mother on terbutaline, beta-blockers, or oral hypoglycemic agents  
 Isolated hepatomegaly  
 Microcephaly  
 Anterior midline defects  
 Gigantism  
 Macroglossia or hemihypertrophy; or any possibility of an inborn error of metabolism 
The onset of hyperinsulinemia is from birth to 18 months (al-Rabeeah et al., 1995, de Lonlay-
Debeney et al., 1999, Dubois et al., 1995, Dunne et al., 2004, Dunne et al., 1997).  
 Insulin concentrations are inappropriately elevated at the time of documented 
hypoglycemia. 
 Transient neonatal hyperinsulinism occurs in macrosomic infants of diabetic mothers 
who have diminished glucagon secretion and endogenous glucose production is 
significantly inhibited. Clinically, these infants are macrosomic and have increasing 
demands for feeding, intermittent lethargy, jitteriness, and frank seizures.  
 Infants with prolonged neonatal hyperinsulinism can be described by small for 
gestational age, patients with perinatal asphyxia, neonates born to mothers with 
toxemia, have high rates of glucose use and often require dextrose infusion for a 
prolonged period of time 
Ketotic hypoglycemia is an uncommon but dramatic illness. It is observed in children 
younger than 5 years who usually become symptomatic after an overnight or prolonged 
fast, especially with illness and poor oral intake. Children often present inexplicably 
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lethargic or frankly comatose, having only marked hypoglycemia with ketonuria (Cranmer, 
2009). 
The symptoms often vary according to age of the children as follows (de Lonlay-Debeney et 
al., 1999, Daly et al., 2003, al-Rabeeah et al., 1995, Dubois et al., 1995, Schwartz, 1997b, 
Schwartz, 1997a, Luber et al., 1998): 
In neonates-  
 Restlessness  
 Hypothermia  
 Tremulousness  
 Brisk Moro reflex  
 Compromised activity  
 Poor feeding  
 Hypotonia  
 Lethargy   
 Apathy  
 Jitteriness  
 Seizures  
 Congestive heart failure  
 Respiratory difficulty 
 Apnea  
 Bradycardia  
 Convulsion  
 Coma and  
 Sudden death 
In older children-  
 Dizziness  
 Hunger  
 Anxiousness  
 Sweating  
 Lethargy  
 Poor feeding  
 Confusion  
 Irritability  
 Convulsion  
 Coma and  
 Sudden death 
Clinical signs of hypoglycemia in SAM  
A large number of patients with hypoglycemia may not have any symptoms or may present 
with severe CNS and cardiopulmonary disturbances. However, in children with SAM who 
need the admission in the pediatric critical care medicine, the most common clinical 
manifestations can take account as  
 Altered level of consciousness,  
 Seizure,  
 Vomiting,  
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 Unresponsiveness, and  
 Lethargy.  
Any child with SAM and acute illness should be evaluated for hypoglycemia, especially 
when history reveals lesser oral intake (Chisti et al., 2010). Persistent or repetitive 
hypoglycemia in infants and children has a major impact on normal brain development and 
function (al-Rabeeah et al., 1995, Bennish et al., 1990). Evidence suggests that hypoxemia 
potentiate hypoglycemia, causing brain damage that may permanently impair neurologic 
development  (Bennish et al., 1990).  
Hypoglycemia is often a sign of severe infection (Bennish et al., 1990). The child should be 
tested for hypoglycemia on admission or whenever lethargy, convulsions or hypothermia 
are found (Butler et al., 1989). If blood glucose cannot be measured, all children with SAM 
suspected to have hypoglycemia should be treated accordingly (Ahmed et al., 1999). 
Otherwise the children with severe malnutrition and hypoglycemia may die within few 
minutes (Chisti et al., 2010, Huq et al., 2007). 
12. Differential diagnosis of hypoglycemia in children (de Lonlay-Debeney et 
al., 1999, Daly et al., 2003, al-Rabeeah et al., 1995, Dubois et al., 1995, 
Schwartz, 1997b, Schwartz, 1997a, Wyngaarden et al., Cosman et al., 1989, 
Stuckey et al., Wall, 2000, Olry, 2002, Belay et al., 1999, CDC, Dellinger et al., 
2008) 
 Adrenal Insufficiency and Adrenal Crisis 
 Hypopituitarism 
 Hypothyroidism and Myxedema Coma 
 Munchausen Syndrome 
 Reye Syndrome 
 Plant Poisoning, Hypoglycemics 
 Shock, Septic 
 Toxicity, Alcohols  
 Toxicity, salicylates 
13. Laboratory studies  
A bedside glucose level is a very cheap rapid diagnostic test, although it may lead to over 
treatment of hypoglycemia (Cranmer, 2009).  
Serum or plasma glucose levels (Serum glucose level is higher than whole blood glucose 
level) (Cranmer, 2009) 
 Arterial and capillary samples may overestimate the plasma glucose concentration by 
10% in non-fasting patients.  
 Whole blood estimation of glucose may underestimate the plasma glucose 
concentration by approximately 10-15% because RBCs contain relatively low 
concentrations of glucose.  
Serum insulin: when blood glucose is less than 40 mg/dL, plasma insulin concentration 
should be less than 5 and no higher than 10 microunits/mL (Cranmer, 2009).  
Urine  (first voided urine dipstick for ketones) (Sperling et al., 2008, Reid et al., 2003) 
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 Absence of large ketones with hypoglycemia suggests that fat is not being metabolized 
from adipose tissue (hyperinsulinism) or that fat cannot be used for ketone body 
formation (enzymatic defects in fatty acid oxidation).  
 Consider urine for organic acid analysis. 
Newborn screening (Sperling et al., 2008, Schwartz, 1997b):  
 Aminoacidemias 
 Urea cycle disorders  
 Organic acidurias and  
 Fatty acid oxidation disorders by electrospray ionization-tandem mass spectrometry.  
First and prompt recognition of these inborn errors of metabolism has the potential to 
reduce morbidity and mortality rates in these infants.  
Imaging studies (Sperling et al., 2008):  
 Celiac angiography to detect adenomas has limited success. There is potential risk of 
causing vascular trauma in infants younger than 2 years.  
14. Consequencess associated with hypoglycemia (Schwartz, 1997b, 
Guideline, 2004, Cranmer, 2009) 
Hypoglycemia is the most common metabolic problem in neonates. Still, the level or 
duration of hypoglycemia that is harmful to an infant's developing brain is not known. 
Major long-term sequelae include: 
 Neurologic damage resulting in mental retardation  
 Recurrent seizure  
 Respiratory distress  
 Developmental delay  
 Heart failure and  
 Personality disorders.  
Some evidence suggests that severe hypoglycemia may impair cardiovascular function.  
15. Management 
In children without severe malnutrition (Cranmer, 2009, Cornblath and Ichord, 2000): 
In the critical care ward, supportive therapy includes oxygen, establishing an intravenous 
(IV) line, and monitoring. 
 If convulsion, unresponsive to correction of hypoglycemia should be managed with 
appropriate anticonvulsants. 
 If there is marked acidosis (pH < 7.1) suggestive of shock or serious underlying disease 
and should be treated appropriately. 
 The goal of treatment is to maintain a blood glucose level of at least 45 mg/dL (2.5 
mmol/L). 
 Children who drink but has intact airway protective reflexes, nasogastric 
administration of oral liquids containing sugar may be performed.  
15.1 Medication  
Hypoglycemia should be treated as soon as possible to prevent complications of 
neurologic damage. Early feeding of the newborn with breast milk or formula is 
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encouraged. For those unable to drink, a nasogastric tube can be used. The mainstay of 
therapy for children that is alert with intact airway protection. For those who cannot 
protect their airway or are unable to drink, nasogastric, intramuscular, intraosseous, or 
intravenous (IV) routes can be used for the following drugs used to raise glucose levels 
(Sperling et al., 2008, Reid et al., 2003):  
 Dextrose  
 Glucagon  
 Diazoxide and  
 Octreotide  
Case reports have shown that nifedipine may help maintain normoglycemia in children 
with persistent hyperinsulinemic hypoglycemia of infancy (PHHI) (Cranmer, 2009).  
Cortisol should not be used because it has minimal acute benefit and may delay the 
diagnosis of the cause of hypoglycemia. Cortisol stimulates gluconeogenesis and causes 
decreased use of glucose, which leads to overall elevated blood glucose and may mask the 
true cause of hypoglycemia (Cranmer, 2009).  
Anti-hypoglycemic agents (agents elevate blood glucose levels) 
Dextrose  
Choice of treatment as it is absorbed from the intestine resulting in rapid increase in blood 
glucose concentration when administered PO (Reid et al., 2003). Give IV dextrose to 
infants of diabetic mothers with transient neonatal hyperinsulinemia for several days 
until hyperinsulinemia abates (Sperling et al., 2008). Avoid hyperglycemia evoking 
prompt insulin release, which may produce rebound hypoglycemia. SGA infants and 
those with maternal toxemia or perinatal asphyxia require dextrose IV infusion rates >20 
mg/kg/min to control levels (Halamek and Stevenson, 1998). Treatment may be 
necessary for 2-4 week .  
Diazoxide  
Aim to increase blood glucose by inhibiting pancreatic insulin release, and possibly through 
an extrapancreatic effect. Hyperglycemic effect starts within an hour and usually lasts a 
maximum of 8 h with normal renal function (Halamek and Stevenson, 1998, Sperling et al., 
2008, Shirland, 2001).  
Octreotide  
Long-acting analog of somatostatin that suppresses insulin secretion for short-term 
management of hypoglycemia (Cranmer, 2009, Fontaine et al., 1972). 
Glucagon (Glucagon Emergency Kit) 
May be used to treat hypoglycemia secondary to hyperinsulinemia and administered to 
patients without initial IV access. Each mL contains 1 mg (ie, 1 unit). Maximal glucose 
concentration occurs between 5-20 min for IV administration and about 30 min for IM 
administration (Cranmer, 2009, Stanley, 1997).  
Surgical opinion  
If hypoglycemia is diagnosed in an infant younger than 3 months, surgical intervention may 
be necessary. Surgical exploration usually is undertaken in severely affected neonates who 
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are unresponsive to glucose and somatostatin therapy (Halamek and Stevenson, 1998, 
Sperling et al., 2008).  
In one most recently conducted study revealed that once the diagnosis is made and if 
medical therapy with diazoxide fails, one should assume that the infant has a K(ATP) 
channel defect and may require surgery (Palladino and Stanley). In this case, the infant 
should be referred to a center that specializes in 18-fluoro L-3,4-dihydroxyphenylalanine 
positron emission tomography scan. This report describes a center specializing in 18-fluoro 
L-3,4-dihydroxyphenylalanine positron emission tomography scan with a team of experts 
consisting of endocrinologists, nurse practitioners, geneticists, radiologists, pathologists, and 
a surgeon. It describes the center's paradigm for managing severe cases of congenital 
hypersplenism (H1) with surgery (Palladino and Stanley). On the other hand another 
indicated that in absence of response to the medical treatment  with diazoxide a limited 
pancreatectomy permits to cure focal HI, while a diffuse HI requires a subtotal 
pancreatectomy with high risk of subsequent diabetes mellitus (Giurgea et al., 2005). 
However over all recommendation with risk benefit from the peer reviewed publications 
and text book are as follows (Halamek et al., 1997b, Sperling et al., 2008, Reid et al., 2003) 
 Near total resection of 85-90% of the pancreas is recommended. 
 Risks include the development of diabetes. 
If hypoglycemia first manifests in infants aged 3-6 months, a therapeutic trial of octreotide, 
diazoxide, steroids, and frequent feedings can be attempted for as long as 2-4 weeks.  
Management of hypoglycemia in children with SAM: 
If the child is conscious and blood glucose is <3mmol/l or 54mg/dl: 
50 ml bolus of 10% glucose or 10% sucrose solution (1 rounded teaspoon of sugar in 3.5 
tablespoons water) is given orally or by nasogastric (NG) tube. The starter diet F-75  or 
“milk suzi” in children above 6 months of age / expressed breast milk (EBM) or “infant 
formula” for children under the age of 6 months of age is given every 30 min for two hours 
(giving one quarter of the two-hourly feed each time) (WHO, 1999, Ahmed et al., 1999). 
Thereafter, two-hourly feeds are continued for first 24-48 hours (Ahmed et al., 1999). 
If the child is unconscious, lethargic or convulsing: 
Sterile 10% glucose (5ml/kg) or 25% dextrose (2ml/kg) is given IV, followed by 50 ml of 10% 
glucose or sucrose by NG tube. Then the starter diet F-75 or “milk suzi”/EBM or “infant 
formula” is given as above (Ahmed et al., 1999, WHO, 1999). A number of studies revealed 
that continuous intravenous dextrose might require in case of uncontrolled hypoglycemia 
(Lilien et al., 1977, Lilien et al., 1980). One of the studies revealed that the treatment of neonatal 
hypoglycemia by constant infusion of glucose at the rate of 8 mg/kg/minute was studied in 22 
hypoglycemic neonates. In that study, 18 neonates glucose levels rose above the hypoglycemic 
range within ten minutes of infusion and in three, within 30 to 50 minutes of infusion. The 
remaining neonate had hyperinsulinemia and responded only to diazoxide. Thus, constant 
glucose infusion was found to be useful therapeutically for neonatal hypoglycemia (Lilien et 
al., 1977). Results from the another study from India revealed that symptomatic hypoglycemia 
should always be treated with a continuous infusion of parenteral dextrose. Neonates needing 
dextrose infusion rates above 12 mg/kg/m should be investigated for refractory causes of 
hypoglycemia. Hypoglycemia has been linked to poor neuro-developmental outcome and 
therefore they recommended aggressive screening and treatment with continuous infusion of 
glucoes (Narayan et al., 2001). 
www.intechopen.com
 
Hypoglycemia in Children Attending the Critical Care Medicine in Developing Countries  
 
41 
Follow up (Cranmer, 2009, Cornblath and Ichord, 2000): 
Any child with documented hypoglycemia not secondary to insulin therapy should be 
admitted in a critical care unit for careful monitoring and diagnostic testing.  
16. Prognosis 
The prognosis is good in asymptomatic neonates with hypoglycemia of short duration. 
Hypoglycemia recurs in 10-15% of infants after adequate treatment (Sperling et al., 2008). 
However, there are no published data on the prevalence of hypoglycemia in severe PEM 
after adequate treatment although it has been thought that it will be more than that of in 
infants. Rebound hypoglycemia is more common if intravenous fluid are extravasated or 
discontinued too early or do not offer oral glucose after IV infusion of glucose especially in 
case SAM (Sperling et al., 2008, Ahmed et al., 1999). Remission of congenital 
hyperinsulinism generally does not occur, but the severity of the disease may decrease with 
time. The prognosis of intellectual function could be worse if the symptoms stay for prolong 
duration and usually associated with neurological sequele (Sperling et al., 2008).  
17. Patients care giver education  
Provide genetic counseling for families with affected children, including information about 
a possible 25% risk of recurrence (DePuy et al., 2009). 
18. Conclusion  
Hypoglycemia in children especially in neonates and SAM is a medical emergency and 
should be tested for hypoglycemia on admission or whenever lethargy, convulsions, 
hypoxemia or hypothermia are found. IV infusion of glucose should be given very urgently 
in order to prevent life threatening consequences. If blood glucose cannot be measured, all 
neonates and children with SAM suspected to have hypoglycemia should be treated 
accordingly.  
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both academic and industrial. In addition to supporting researcher and development, this book should be
suitable for teaching.
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